Clinical Evaluation of Oral Rinse for Xerostomia

Status Completed

Clinical Trial Summary

Xerostomia causes a difficulty in eating, have irritated oral tissues, and a poor quality of life. The new oral rinse was designed to reduce the symptoms and improve the patient's quality of life. The objectives of the clinical study is to evaluate the effectiveness of the oral rinse comparing to the placebo product and the control product in the market. This is a randomized double-blind placebo controlled crossover study with 39 patients receiving treatment. Patients will be randomly allocated to three treatment groups. Patients will use the assigned oral rinse four times a day for two weeks. Dry mouth symptoms and other endpoints will be assessed subjectively and objectively at baseline and Day 14. Patients will be assigned to another treatment after one week wash-out period.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Xerostomia

Clinical Trial Details

NCT number	NCT04289051
Study type	Interventional
Source	Sunstar Americas
Contact
Status	Completed
Phase	N/A
Start date	August 19, 2020
Completion date	February 4, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05342272` - Comparison of Gum® HydralTM Moisturizing Gel and Biotene® Oral Gel in Dry Mouth Sensation Reduction	Phase 3
Completed	`NCT03302676` - The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors	N/A
Completed	`NCT02375451` - Effect of Childhood Radioiodine Therapy on Salivary Function	N/A
Completed	`NCT01272570` - Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors	N/A
Completed	`NCT00656513` - Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer	Phase 2/Phase 3
Completed	`NCT00911768` - Effect of Korean Red Ginseng (KRG) on Dry Mouth	Phase 4
Completed	`NCT00332618` - Efficacy Study of Oxygenated Glycerol Triesters to Treat Xerostomia	Phase 2
Completed	`NCT03494985` - A Clinical Study to Evaluate the Efficacy of Three Dry Mouth Relief Products Versus Water	N/A
Completed	`NCT05058430` - SaliPen Human Factors Study for OTC Labeling	N/A
Recruiting	`NCT02705937` - Early Phase Study Comparing the Effectiveness of a Dairy Product With the Reference Treatment Aequasyal® on Dry Mouth Symptoms in Patients Suffering From Xerostomia Caused by Psychotropic Medications.	N/A
Completed	`NCT05247008` - Effectiveness of Thyme Honey in Management of Xerostomia in ESRD	N/A
Recruiting	`NCT03632096` - Photobiomodulation in Salivary Production of Patients With Xerostomy	Phase 2
Not yet recruiting	`NCT04323384` - The Effect of Biotene® on the Symptoms of Xerostomia and Mastication and Swallowing	N/A
Not yet recruiting	`NCT03530735` - Finger-prick Autologous Blood (FAB) for Use in Dry Mouth	N/A
Active, not recruiting	`NCT03176368` - Coconut Oil: Managing Radiation-Induced Xerostomia	N/A
Enrolling by invitation	`NCT06122636` - Efficacy of a Probiotic and Microbiological Analysis on Oral Complications Induced by Antineoplastic Therapies in Patients With HNC	N/A
Completed	`NCT03611283` - Topical Management of Xerostomia With Dry Mouth Products	N/A
Completed	`NCT02682199` - Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation
Withdrawn	`NCT01960101` - Development of a Milk Product Substitution for Patients Suffering From Xerostomia Caused by Medication	N/A
Completed	`NCT02317172` - Efficacy of Novel Edible Gel-based Artificial Saliva in Thai Geriatric Populations With Systemic Diseases	N/A